184 related articles for article (PubMed ID: 10720592)
1. Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Saris JJ; van Dijk MA; Kroon I; Schalekamp MA; Danser AH
Hypertension; 2000 Mar; 35(3):764-8. PubMed ID: 10720592
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism.
Danser AH; Deinum J; Osterop AP; Admiraal PJ; Schalekamp MA
J Hypertens; 1999 Dec; 17(12 Pt 2):1867-72. PubMed ID: 10703882
[TBL] [Abstract][Full Text] [Related]
3. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
MaassenVanDenBrink A; de Vries R; Saxena PR; Schalekamp MA; Danser AH
Cardiovasc Res; 1999 Nov; 44(2):407-15. PubMed ID: 10690317
[TBL] [Abstract][Full Text] [Related]
4. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm.
van Dijk MA; Kroon I; Kamper AM; Boomsma F; Danser AH; Chang PC
J Cardiovasc Pharmacol; 2000 Mar; 35(3):484-90. PubMed ID: 10710136
[TBL] [Abstract][Full Text] [Related]
5. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
[TBL] [Abstract][Full Text] [Related]
6. Venoconstriction by angiotensin II in the human forearm is inhibited by losartan but not by nicardipine.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 1998 Jan; 31(1):50-5. PubMed ID: 9456277
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries.
Padmanabhan N; Jardine AG; McGrath JC; Connell JM
Circulation; 1999 Jun; 99(22):2914-20. PubMed ID: 10359736
[TBL] [Abstract][Full Text] [Related]
8. Vascular angiotensin conversion in humans.
Webb DJ; Collier JG
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S40-4. PubMed ID: 2438489
[TBL] [Abstract][Full Text] [Related]
9. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
[TBL] [Abstract][Full Text] [Related]
10. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
11. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
[TBL] [Abstract][Full Text] [Related]
12. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.
Benjamin N; Cockcroft JR; Collier JG; Dollery CT; Ritter JM; Webb DJ
J Physiol; 1989 May; 412():543-55. PubMed ID: 2557432
[TBL] [Abstract][Full Text] [Related]
13. Influence of indomethacin and L-NMMA on vascular tone and angiotensin II-induced vasoconstriction in the human forearm.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Blood Press; 1997 Sep; 6(5):279-85. PubMed ID: 9359998
[TBL] [Abstract][Full Text] [Related]
14. Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans.
McDonald JE; Padmanabhan N; Petrie MC; Hillier C; Connell JM; McMurray JJ
Circulation; 2001 Oct; 104(15):1805-8. PubMed ID: 11591618
[TBL] [Abstract][Full Text] [Related]
15. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors.
Maruyama R; Hatta E; Yasuda K; Smith NC; Levi R
J Pharmacol Exp Ther; 2000 Jul; 294(1):248-54. PubMed ID: 10871319
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin II and losartan in the forearm of patients with essential hypertension.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
J Hypertens; 1998 Sep; 16(9):1299-305. PubMed ID: 9746117
[TBL] [Abstract][Full Text] [Related]
19. Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat.
Houben AJ; Kroon AA; de Haan CH; Fuss-Lejeune MJ; de Leeuw PW
Cardiovasc Drugs Ther; 2000 Dec; 14(6):657-63. PubMed ID: 11300367
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
